Tag: Central Drugs Standard Control Organisation
July 3, 2023
Intellectual Property | Patent
Intellectual Property | Patent
When medicines are out of reach: Managed Access Program...
Before a new drug, biologic or medical device is approved and authorized for market launch, it has to undergo a long and complex process involving extensive testing and clinical trials to ensure its safety and efficacy. However, for patients who have exhausted all other options, sometimes an unapproved or pre-approved or investigational drug could be the only hope. ......